聯博-國際醫療基金ED月配級別美元
22.04美元0.07(0.32%)
2023/12/05更新
為求達致此投資目標,投資管理人預期在任何時候將本基金至少80%的總資產投資於主要從事健康護理及健康護理相關行業(「健康護理行業」)的公司(主要從事與診斷、治療及預防疾病或其他醫學疾病有關的產品及服務的發明、開發、供應、生產或分銷的公司)發行的證券,且在任何情況下,本基金投資於此等證券的總資產將不會少於本基金總資產的三分之二。
大型 | |||
---|---|---|---|
中型 | |||
小型 | |||
價值型 | 均衡型 | 增長型 |
John Fogarty is a Senior Vice President and Portfolio Manager for U.S. Growth Equities at AB, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the U.S., having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Varden Partners. Mr. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Mr. Fogarty holds a B.A. in history from Columbia University and is a CFA charterholder.
於2011年9月加入聯博,目前擔任副總裁暨研究分析師,負責全球成長型醫療類股。在此之前,Vinay曾於American Century Investments 擔任資深投資分析師,負責兩檔國內基金之全球醫療類股研究工作,時間長達三年半。在此之前,Vinay曾於貝爾斯登旗下之生技股票研究團隊,擔任副總監一職。Vinay擁有美國紐約大學之生物學學士學位,以及特許財務分析師資格。任職地點:紐約。